Cough Responses to Tussive Agents in Health and Disease (NCT01297790) | Clinical Trial Compass
CompletedNot Applicable
Cough Responses to Tussive Agents in Health and Disease
United Kingdom102 participantsStarted 2009-11
Plain-language summary
The sensitivity of a persons cough reflex can be measured by getting them to breath in (inhale) irritant chemicals. The purpose of this clinical research study is to test the sensitivity of the cough reflex to a variety of chemicals that can be inhaled to see if coughing responses are different between healthy people and people with respiratory problems that make them cough.
Who can participate
Age range
18 Years – 75 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* General
* Adult subjects aged 18 years and over
* Meet criteria for subject groups as outlined below
(1) Healthy volunteers
* Non-smokers
* No history of respiratory disease
(2) Healthy smokers
* Current smokers with smoking history of ≥10 pack years
* Spirometry within normal limits i.e. FEV1\>80% predicted and FEV1/FVC ratio \>75% predicted
(3) Asthma
* Physician diagnosis of asthma
* Airways hyperresponsiveness to methacholine; PC20\<16mg/ml (within last 2 years)
* Non-smokers or ex-smoker with smoking history of ≤10 pack years
(4) COPD
* Physician diagnosis of COPD
* Ex-smokers with smoking history of ≥20 pack years
* Spirometry demonstrating airflow obstruction i.e. FEV1/FVC ratio \<70%
(5) Chronic Cough
* History of a dry cough for \>8 weeks
* Normal CXR
* Non-smokers or ex-smoker with smoking history of ≤10 pack years
Exclusion Criteria:
* 1\) Symptoms of upper respiratory tract infection within the last 6 weeks 2) Participation in another clinical trial of an investigational drug within the last 4 weeks 3) Use of medication likely to alter cough reflex sensitivity i.e. ACE inhibitors, codeine phosphate, morphine sulphate, 4) Patients with severe respiratory disease i.e. FEV1 \< 1 litre, 5) Significant medical co-morbidities likely to affect ability to participate in the trial or affect cough reflex sensitivity e.g. diabetes, stroke, Parkinson's disease, multiple sclerosis etc.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.